BioWorld

Sep. 5, 2007

View Archived Issues

J. Craig Venter Institute Publishes J. Craig Venter Genome Sequence

Clinical Data's Vilazodone Positive In Phase III Study

GNI Gains New Listing In Japan Raises $7.7M For Drug Discovery

Anacor Seeks $57.5M In IPO For Topical Boron-Based Pipeline

Other News To Note

Clinic Roundup

NeurogesX Reports Positive Phase III Study Of NGX-4010

NeurogesX Inc. reported the pain patch NGX-4010 met primary and secondary endpoints in a third Phase III trial, and the second in patients with postherpetic neuralgia. (BioWorld Today) Read More

Acambis Smallpox Vaccine Finally Wins U.S. Approval

Today's news in brief

BioWorld

BioWorld briefs for March 19, 2026.

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

Keros reports beneficial effects of RKER-065 in ALS model

BioWorld Science

Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.

News in brief

BioWorld Asia

BioWorld Asia briefs for March 17, 2026

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...